SCHEMBL29125465

SCHEMBL29125465

Fc1ccc(OC(F)C(F)F)c(CNC2CC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 3/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KCNH2 Q12809 6/20 0.39
▸ TACR1 P25103 1/20 0.39
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30688863 0.82 NTRK1 (0.45) HTR2AHTR2CHTR2BKDM1AMAOA
SCHEMBL2471248 0.81 KDM1A (0.59) HTR2AHTR2CHTR2BKDM1AMAOA
SCHEMBL28613921 0.75 ALDH1A1 (0.44) HTR2AHTR2CHTR2BKDM1AMAOA
SCHEMBL30802465 0.71 BCHE (0.63) HTR2AHTR2CKDM1AKDM4EBCHE
SCHEMBL16767313 0.69 BACE1 (0.38) HTR2AHTR2CHTR2BKDM4EMEN1
SCHEMBL30933758 0.69 NPBWR1 (0.48) HTR2AKDM1AMAOAMAOBKDM4E
SCHEMBL30933761 0.69 NPBWR1 (0.48) HTR2AKDM1AMAOAMAOBKDM4E
SCHEMBL23105979 0.68 BCHE (0.47) HTR2AHTR2CHTR2BKDM4EMEN1
SCHEMBL696317 0.68 BCHE (0.50) BCHEACHEBACE1CYP2D6
SCHEMBL28785597 0.68 OPRL1 (0.50) HTR2AHTR2CKDM4EMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113278022-B Pyrazolopyrimidine compound, pharmaceutical composition and application thereof 南京纳丁菲医药科技有限公司 2023-12-12 — — CN disclosed
Send feedback